By www.reliablebusinessinsights.com
Global Respiratory Syncytial Virus (RSV) Therapeutics Market Research Report 2023 Story
86
$ 2900
Respiratory Syncytial Virus (RSV) Therapeutics Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Roche AstraZeneca Merck AbbVie Bausch Health GlaxoSmithKline ReViral Gilead Sciences Teva Pharmaceutical